Screener
Ultragenyx Pharmaceutical RARE Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's inventories?
- Ultragenyx Pharmaceutical (RARE) reported inventories of $59M in Q2 2026.
- How has Ultragenyx Pharmaceutical's inventories changed year-over-year?
- Ultragenyx Pharmaceutical's inventories increased by 26.9% year-over-year, from $46.5M to $59M.
- What is the long-term trend for Ultragenyx Pharmaceutical's inventories?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's inventories has grown at a 31.9% compound annual growth rate (CAGR), from $13.05M to $52M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Ultragenyx Pharmaceutical's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude